Entering the Era of Disease-Modifying Treatments for AD: Taking Stock of Today and Looking to Tomorrow – Supported by Prothena This symposium discussed how the efficacy of anti-amyloid beta (Aβ) monoclonal antibodies (mAbs) was evaluated in clinical trials (both for […] Read more
Evaluating Donanemab’s Efficacy and its Role in Alzheimer’s Disease Treatment This session brought together esteemed experts Curtis P. Schrieber, MD, Giacomo Koch, MD, PhD and Miranda E. Orr, PhD to […] Read more
Detecting Brain Amyloid Burden with PET GE Healthcare brings its 4-module, e-learning certification course on detecting brain amyloid burden with PET. In this module, learn about […] Read more